MedPath

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

Active, not recruiting
Conditions
Bladder Cancer
Interventions
Behavioral: questionnaires
Other: Saliva and/or urine sample
Registration Number
NCT02400944
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Patients ≥18 years old AND
  • Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)
Read More
Exclusion Criteria
  • Patients are ineligible for the study if they have/had:
  • Histologically-confirmed NMIBC diagnosed >36 months prior to enrollment
  • Cystectomy prior to enrollment
  • Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
  • Non English-speaking
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patients with bladder cancerquestionnaires-
patients with bladder cancerSaliva and/or urine sample-
Primary Outcome Measures
NameTimeMethod
recurrence1 year

will be defined as the presence of pathologically-confirmed NMIBC lesion \>8 weeks after diagnosis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Commack

🇺🇸

Commack, New York, United States

Memorial Sloan Kettering Westchester

🇺🇸

Harrison, New York, United States

© Copyright 2025. All Rights Reserved by MedPath